the continual presence of c3d but not igg glomerular capillary deposition in stage i idiopathic membranous nephropathy in patients receiving corticosteroid treatmentc3d的持续存在,但不是肾小球毛细血管免疫球蛋白沉积阶段我接受皮质类固醇治疗特发性膜性肾病的病人.pdfVIP

Zhang et al. Diagnostic Pathology 2012, 7:109 /content/7/1/109 RESEARCH Open Access The continual presence of C3d but not IgG glomerular capillary deposition in stage I idiopathic membranous nephropathy in patients receiving corticosteroid treatment 1,2 1* 1 1 3 Rui Zhang , Zhi-yong Zheng , Jian-song Lin , Li-juan Qu and Feng Zheng Abstract Background: Pathologic diagnosis of stage I idiopathic membranous nephropathy (MN-I) requires electron microscopy or immunohistochemistry that shows a glomerular capillary staining pattern of IgG and C3. However, it is not uncommon that renal biopsy did not obtain sufficient material for electron microscopy and that IgG and C3 staining in glomeruli largely lost at biopsy due to corticosteroid treatment. Since C3d is one of the final degradation products of C3 that is more stable in vivo, we determine if C3d staining could be used as a novel immunohistochemical marker for MN-I. Methods and results: 74 MN-I patients with electron microscopy proven MN-I were examined by immunoperoxidase staining of C3d. Intensive C3d staining was present in glomerular capillary like the staining pattern of IgG and C3 in MN-I. Importantly, in 40 MN-I patients who underwent corticosteroid treatment at biopsy the intensity and glomerular capillary pattern of C3d staining remained largely intact while the staining for IgG had substantially reduced and the pattern of glomerular capillary staining became unrecognizable. Conclusions: C3d glomerular capillary staining may be a novel marker for pathologic diagnosis of MN-I that is continuously present at biopsy in patient who has received corticosteroid treatment. Virtual slides: The virtual slide(s) for this article can be found here: http://www.diag